N-(4-(1H-pyrrol-1-yl)phenyl)-4-methoxybenzenesulfonamide, 98%, 5g

Pentanethioamide, 95%, 500mg

(1s)-1-(2-Methylphenyl)ethan-1-ol, 97%, 500mg

5-chloro-3-{[(4-methylphenyl)methyl]sulfanyl}-1,2,4-thiadiazole, 95.0%, 1g

2,6-Difluoro-4-methylbenzaldehyde, 95.0%, 1g

Ammonium ((1R,3S,4S,7R)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate, 95.0%, 25g

Magnesium sulphate heptahydrate, min. 99%, pa, ACS, 500 g, plastic packaging.

Cryogenic vials Round bottom inside thread, 2 ml, 100 Piece(s)

1-Methyl-6-oxopiperidine-2-carboxylic acid, 98%, 1g

2-Methyl-6-(3-thienyl)pyridine, 97.0%, 2g

Tributyl(methyl)phosphonium dimethyl phosphate, 97.0%, 500g

5-Phenylisoxazol-3-amine hydrochloride, 98%, 100mg

2-Amino-5-chlorobenzenethiol, 95.0%, 250mg